ArticleCardiovascular diabetology2020

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.

Guntram Schernthaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.